Tonghua Dongbao Pharmaceutical
Tonghua · Founded 1985
About Tonghua Dongbao Pharmaceutical
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
Company Facts
- Founded: 1985
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $283.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2020)
- Ticker: sse:600867
- Website: thdb.com
- Phone: 0435-5088008
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tonghua-dongbao-pharmaceutical-100018 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.